Jump to content

Study, 2018: "Anxiolytics targeting GABAA receptors: Insights on etifoxine"


[La...]

Recommended Posts

"RESULTS:  Considering the adverse effects of current treatments aimed at increasing inhibitory controls, optimisation of existing pharmacotherapies is of crucial importance. Among the alternative compounds targeting the GABAergic system, translocator protein (TSPO) ligands, such as etifoxine (EFX), which promote endogenous neurosteroidogenesis, are emerging as promising candidates for anxiety relief. In several papers comparing the efficacy of benzodiazepines and EFX, EFX showed interesting properties with limited side effects. Indeed, neurosteroids are potent GABAAR modulators with highly underrated anxiolytic properties."

 

https://www.ncbi.nlm.nih.gov/pubmed/30204559

Link to comment
Share on other sites

I don't know ... it appears to be better than benzos in many ways but, there appears to be a small percentage of people at least in France who suffered some liver damage. But, look what a large percentage of people who use benzodiazepines long term who suffer multi sx damage ...
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...